RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Vascular Remodeling
Accession: DOID:9004771
browse the term
Definition: The active alterations of vascular wall structures, often leading to elevated VASCULAR RESISTANCE. It is associated with AGING; ATHEROSCLEROSIS; DIABETES MELLITUS; HYPERTENSION; PREGNANCY; PULMONARY HYPERTENSION; and STROKE, but is also a normal part of EMBRYOGENESIS.
Synonyms: exact_synonym: Pulmonary Arterial Remodeling; Pulmonary Arterial Remodelings; Vascular Remodelings
primary_id: MESH:D066253
G
Acvrl1
activin A receptor like type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26540443
NCBI chr 7:132,239,200...132,256,592
Ensembl chr 7:132,239,729...132,256,591
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25259750 PMID:27678262
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Bmpr2
bone morphogenetic protein receptor type 2
IMP
RGD
PMID:25593290
RGD:38500244
NCBI chr 9:61,192,718...61,307,280
Ensembl chr 9:61,190,566...61,301,809
G
Bmpr2em1Ang
bone morphogenetic protein receptor type 2; ZFN induced mutant 1, Ang
IMP
RGD
PMID:25593290
RGD:38500244
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27678262
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr4
C-X-C motif chemokine receptor 4
treatment
IMP
RGD
PMID:21294880
RGD:6480473
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Egfr
epidermal growth factor receptor
treatment
IMP
RGD
PMID:31264901
RGD:38599217
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Gata2
GATA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
G
Gja1
gap junction protein, alpha 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36720419
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Mir125a
microRNA 125a
treatment
IDA
RGD
PMID:29700287
RGD:26884455
NCBI chr 1:58,677,626...58,677,710
Ensembl chr 1:58,677,626...58,677,710
G
Senp1
SUMO specific peptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 7:129,163,173...129,226,766
Ensembl chr 7:129,165,774...129,221,598
G
Serpine1
serpin family E member 1
treatment
ISO
RGD
PMID:26856544
RGD:11073690
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Twist1
twist family bHLH transcription factor 1
IEP
protein:increased expression:lung
RGD
PMID:25593290
RGD:38500244
NCBI chr 6:50,674,910...50,676,904
Ensembl chr 6:50,674,678...50,677,653
G
Vim
vimentin
IEP
protein:increased phosphorylation:lung
RGD
PMID:25593290
RGD:38500244
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Etv2
ETS variant transcription factor 2
ameliorates
ISO
RGD
PMID:29191922
RGD:156451665
NCBI chr 1:85,890,562...85,894,025
Ensembl chr 1:85,890,559...85,893,431
G
Ifnb1
interferon beta 1
ameliorates
ISO
RGD
PMID:17466308
RGD:401854230
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Serpine1
serpin family E member 1
treatment
IDA
associated with Hypertension
RGD
PMID:26693246
RGD:11073698
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all